The US heart valve device market is large and growing, driven by the continued adoption and launch of THV devices, as well as an aging population.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for heart valve devices in the US across a 10-year period.
Millennium Research Group has up-to-date reports on a wide range of medical device markets worldwide.
* Medtronic became the second competitor in the lucrative US TAVR market, launching its CoreValve product in early 2014.
* The first TMVR device, Abbott Laboratories' MitraClip, was approved and launched at the end of 2013.
* The US heart valve device market is dominated by four entrenched competitors.
* Tissue heart valves and surgical annuloplasty repair devices face competition from THV devices.
Geographies Covered: US
Market Forecast Features: Based on primary research with industry professionals, Millennium Research Group uses its proprietary forecasting model to provide an in-depth examination of current and future trends in procedure volumes, unit sales, ASPs, and market values over a 10-year period (2013-2023).
Competitive Analysis: Millennium Research Group provides a detailed analysis of the competitive landscape and market shares for leading competitors.
Browse more Cardiovascular Device Market Research Reports